Ashling Partners vs Ozemio: Revenue, Funding & Team Size Compared
Ashling Partners generates $25M in revenue; Ozemio generates $25.3M. Ozemio and Ashling Partners are close to the same size by revenue. The table below compares Ashling Partners and Ozemio on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $25M | $25.3M |
| Valuation | $150M | Not disclosed |
| Team size | 193 | 230 |
| Founded | 2017 | Not disclosed |
| HQ | Chicago, United States | Billerica, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Ashling Partners at a glance
Ashling Partners generates $25M in revenue with 193 employees, headquartered in Chicago, United States.
- Revenue
- $25M
- Valuation
- $150M
- Team size
- 193
- Founded
- 2017
Global consulting firm that works with intelligent automation technologies to drive better employee engagement for clients
Ozemio at a glance
Ozemio generates $25.3M in revenue with 230 employees, headquartered in Billerica, United States.
- Revenue
- $25.3M
- Team size
- 230
Ozemio: Talent transformation company driving enhanced performance through human-centric solutions. Consulting, content, technology, and people. Spanning divisions in Edtech, IT Staffing, Digital Transformation, LearnTech, and Talent…
Other Ashling Partners alternatives
Ashling Partners competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Ashling Partners vs Ozemio: frequently asked questions
Is Ashling Partners or Ozemio bigger?
Ozemio is the bigger company by revenue, at $25.3M against $25M for Ashling Partners.
How much revenue does Ashling Partners make?
Ashling Partners generates $25M in annual revenue with a team of 193.
How much revenue does Ozemio make?
Ozemio generates $25.3M in annual revenue with a team of 230.